Treatment in Germany helps international patients with personalized treatment plans, specialist appointments, hospital support, travel assistance, and follow-up care.
Triple-negative breast cancer (TNBC) is negative for estrogen receptors (ER), progesterone receptors (PR), and HER2, so it does not have the hormone-receptor or HER2 targets used by several other breast cancer treatments. Triple-negative breast cancer treatment therefore relies more heavily on chemotherapy, immunotherapy, and other systemic approaches. Which combination is used, and in what sequence, depends on disease stage, tumor biology, biomarker results, and how the disease has responded to treatment so far.
treatmentingermany.de